166 related articles for article (PubMed ID: 32033361)
1. Barriers and Challenges in Performing Pharmacokinetic Studies to Inform Dosing in the Neonatal Population.
O'Hara K; Martin JH; Schneider JJ
Pharmacy (Basel); 2020 Feb; 8(1):. PubMed ID: 32033361
[TBL] [Abstract][Full Text] [Related]
2. Suggestions for Model-Informed Precision Dosing to Optimize Neonatal Drug Therapy.
Euteneuer JC; Kamatkar S; Fukuda T; Vinks AA; Akinbi HT
J Clin Pharmacol; 2019 Feb; 59(2):168-176. PubMed ID: 30204236
[TBL] [Abstract][Full Text] [Related]
3. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
4. Unpacking the 'black box of horrendousness': a qualitative exploration of the barriers and facilitators to conducting trials involving adults lacking capacity to consent.
Shepherd V; Hood K; Wood F
Trials; 2022 Jun; 23(1):471. PubMed ID: 35668460
[TBL] [Abstract][Full Text] [Related]
5. Clinical trials of medicines in neonates: the influence of ethical and practical issues on design and conduct.
Turner MA
Br J Clin Pharmacol; 2015 Mar; 79(3):370-8. PubMed ID: 25041601
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic studies in children: recommendations for practice and research.
Barker CIS; Standing JF; Kelly LE; Hanly Faught L; Needham AC; Rieder MJ; de Wildt SN; Offringa M
Arch Dis Child; 2018 Jul; 103(7):695-702. PubMed ID: 29674514
[TBL] [Abstract][Full Text] [Related]
7. Gentamicin pharmacokinetics and dosing in neonates with hypoxic ischemic encephalopathy receiving hypothermia.
Frymoyer A; Meng L; Bonifacio SL; Verotta D; Guglielmo BJ
Pharmacotherapy; 2013 Jul; 33(7):718-26. PubMed ID: 23553582
[TBL] [Abstract][Full Text] [Related]
8. Lidocaine (lignocaine) dosing regimen based upon a population pharmacokinetic model for preterm and term neonates with seizures.
van den Broek MP; Huitema AD; van Hasselt JG; Groenendaal F; Toet MC; Egberts TC; de Vries LS; Rademaker CM
Clin Pharmacokinet; 2011 Jul; 50(7):461-9. PubMed ID: 21651313
[TBL] [Abstract][Full Text] [Related]
9. Use of Modeling and Simulations to Determine Raltegravir Dosing in Neonates: A Model for Safely and Efficiently Determining Appropriate Neonatal Dosing Regimens: IMPAACT P1110.
Clarke DF; Mirochnick M; Acosta EP; Capparelli E; Chain A; Teppler H; Smith B; Lommerse J;
J Acquir Immune Defic Syndr; 2019 Dec; 82(4):392-398. PubMed ID: 31658182
[TBL] [Abstract][Full Text] [Related]
10. Population pharmacokinetics and dosing optimization of mezlocillin in neonates and young infants.
Zhou J; Jiang L; Zhang ZL; Wang ZR; Zhang YX; Lin X; Tang BH; Yao BF; Guo ZX; Yang JJ; Van Den Anker J; Wu YE; Zhao W
J Antimicrob Chemother; 2022 Jul; 77(8):2238-2244. PubMed ID: 35662337
[TBL] [Abstract][Full Text] [Related]
11. Population pharmacokinetics and dosing optimization of azlocillin in neonates with early-onset sepsis: a real-world study.
Wu YE; Wang T; Yang HL; Tang BH; Kong L; Li X; Gao Q; Li X; Yao BF; Shi HY; Huang X; Wang WQ; Jacqz-Aigrain E; Allegaert K; van den Anker J; Tian XY; Zhao W
J Antimicrob Chemother; 2021 Feb; 76(3):699-709. PubMed ID: 33188385
[TBL] [Abstract][Full Text] [Related]
12. Predicting neonatal pharmacokinetics from prior data using population pharmacokinetic modeling.
Wang J; Edginton AN; Avant D; Burckart GJ
J Clin Pharmacol; 2015 Oct; 55(10):1175-83. PubMed ID: 25907280
[TBL] [Abstract][Full Text] [Related]
13. Developmental Population Pharmacokinetics and Dosing Optimization of Cefepime in Neonates and Young Infants.
Zhao Y; Yao BF; Kou C; Xu HY; Tang BH; Wu YE; Hao GX; Zhang XP; Zhao W
Front Pharmacol; 2020; 11():14. PubMed ID: 32116695
[TBL] [Abstract][Full Text] [Related]
14. Neonatal medicines research: challenges and opportunities.
Samardzic J; Turner MA; Bax R; Allegaert K
Expert Opin Drug Metab Toxicol; 2015 Jul; 11(7):1041-52. PubMed ID: 25958820
[TBL] [Abstract][Full Text] [Related]
15. Quantitative clinical pharmacology practice for optimal use of antibiotics during the neonatal period.
Samardzic J; Allegaert K; Wilbaux M; Pfister M; van den Anker JN
Expert Opin Drug Metab Toxicol; 2016; 12(4):367-75. PubMed ID: 26817821
[TBL] [Abstract][Full Text] [Related]
16. Population pharmacokinetics of phenobarbital by mixed effect modelling using routine clinical pharmacokinetic data in Japanese neonates and infants: an update.
Yukawa M; Yukawa E; Suematsu F; Takiguchi T; Ikeda H; Aki H; Mimemoto M
J Clin Pharm Ther; 2011 Dec; 36(6):704-10. PubMed ID: 22023343
[TBL] [Abstract][Full Text] [Related]
17. Population pharmacokinetics and dose optimization of vancomycin in neonates.
Lee SM; Yang S; Kang S; Chang MJ
Sci Rep; 2021 Mar; 11(1):6168. PubMed ID: 33731764
[TBL] [Abstract][Full Text] [Related]
18. Lidocaine as treatment for neonatal seizures: Evaluation of previously developed population pharmacokinetic models and dosing regimen.
Favié LMA; Huitema ADR; van den Broek MPH; Rademaker CMA; de Haan TR; van Straaten HLM; Simons SHP; Rijken M; Nuytemans DHGM; Egberts TCG; Groenendaal F;
Br J Clin Pharmacol; 2020 Jan; 86(1):75-84. PubMed ID: 31663153
[TBL] [Abstract][Full Text] [Related]
19. Facilitating pharmacokinetic studies in children: a new use of dried blood spots.
Patel P; Mulla H; Tanna S; Pandya H
Arch Dis Child; 2010 Jun; 95(6):484-7. PubMed ID: 20501544
[TBL] [Abstract][Full Text] [Related]
20. PBPK in Preterm and Term Neonates: A Review.
Michelet R; Bocxlaer JV; Vermeulen A
Curr Pharm Des; 2017; 23(38):5943-5954. PubMed ID: 28990526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
